What You Should Know
- The Deal: Guideway Care, a leader in evidence-based patient activation, has acquired and integrated Waypoint Healthcare Solutions. Waypoint’s entire team, including founders Lisa McDermott and David Bradshaw, has joined Guideway.
- The Core Problem: Health systems have invested heavily in Electronic Health Records (EHRs), digital front doors, and population health analytics. However, a massive “execution gap” remains in the non-clinical layer. Identifying a social determinant of health (SDoH) or logging a referral in the EHR does not guarantee the patient will actually book the appointment, leading to revenue leakage and poor value-based care performance.
- The Technology Strategy: Waypoint brings specialized AI and virtual agent tools to the table. Rather than pitching AI as a standalone automation product that replaces staff, Guideway is utilizing it as an “amplification layer.” AI handles real-time detection, pattern recognition, and scalable orchestration, empowering human Activation Specialists to focus on contextual judgment and empathy.
- The RCM Impact: By governing the execution layer between encounters, the unified platform aims to directly improve the revenue cycle through increased referral closure, reduced avoidable emergency department utilization, and gap closure for at-risk populations.
Moving from Engagement to Activation
For years, digital health vendors have sold “patient engagement” tools—usually manifesting as generic SMS blasts or passive patient portals. But engagement is not execution. Guideway Care is pivoting the industry toward “Patient Activation.” The difference is measurable completion. It is the discipline of ensuring that high-intent digital access demand actually converts into a scheduled visit, or that diagnostic findings don’t decay in the space between clinical encounters.
“For years, the biggest barrier to delivering measurable clinical and financial outcomes has not been effort or investment — it has been effective execution,” said David Bradshaw, now CEO of Waypoint. “Healthcare has no shortage of strategy or technology. What it lacks are proven solutions that ensure the next right step is completed at scale.
AI as an Amplification Layer
The most compelling aspect of this acquisition is how the combined entity views artificial intelligence. In the current health-tech hype cycle, AI is frequently pitched as a standalone automation tool designed to replace human labor. Guideway is taking a much more pragmatic, effective approach. Waypoint brings advanced AI and virtual agent tools that serve as an “amplification layer” within a governed ecosystem.
The AI handles the heavy lifting of real-time risk detection, pattern recognition, and scalable workflow orchestration. This prevents patients from slipping through the cracks. But when a patient hits a complex logistical or emotional barrier, the system seamlessly routes them to a human Activation Specialist. The technology handles the scale; the human handles the relational continuity and empathy.
“Healthcare payers and providers have invested heavily in electronic health records, digital front doors, nurse triage platforms, population health analytics, and enterprise AI,” said Craig Parker, Chief Executive Officer of Guideway Care. “Yet enterprise performance still depends on whether patients or members complete the right actions at the right time. The addition of Waypoint’s team and technology gives us additional AI and virtual agent tools to expand our reach and improve our efficiency while allowing us to tailor every interaction to each patient’s preferred activation pathway. Together, we now deliver a unified and integrated Activation Intelligence solution that connects payer and provider strategy directly to measurable completion across access, referral management, care transitions, chronic condition management, and enterprise growth,” Parker added.
